Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack A Roth

Showing results (241-250 of 352) with videos related to

Pageof 36
Sort By:
Plos One|June 9, 2015
Exogenous Restoration of TUSC2 Expression Induces Responsiveness to Erlotinib in Wildtype Epidermal Growth Factor Receptor (EGFR) Lung Cancer Cells through Context Specific Pathways Resulting in Enhanced Therapeutic EfficacyBingbing Dai, Shaoyu Yan, Humberto Lara-Guerra, et al.
The Annals of Thoracic Surgery|August 18, 2018
Perioperative Outcomes for Stage I Non-Small Cell Lung Cancer: Differences Between Men and WomenDavid B Nelson, Danica J Lapid, Kyle G Mitchell, et al.
The Annals of Thoracic Surgery|November 1, 2020
Liposomal Bupivacaine Intercostal Block Is Important for Reduction of Pulmonary ComplicationsErin M Corsini, Kyle G Mitchell, Nicolas Zhou, et al.
Journal of the National Cancer Institute|November 1, 2007
Proliferative changes in the bronchial epithelium of former smokers treated with retinoidsWalter N Hittelman, Diane D Liu, Jonathan M Kurie, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 18, 2018
Genetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patientsBoris Sepesi, Yuanqing Ye, Kyle G Mitchell, et al.
Clinical Pharmacology and Therapeutics|April 24, 2014
Inflammation-related genetic variations and survival in patients with advanced non-small cell lung cancer receiving first-line chemotherapyXia Pu, Michelle A Hildebrandt, Charles Lu, et al.
Scientific Reports|January 25, 2022
Combined MEK/MDM2 inhibition demonstrates antitumor efficacy in TP53 wild-type thyroid and colorectal cancers with MAPK alterationsSeyed Pairawan, Argun Akcakanat, Scott Kopetz, et al.
The Annals of Thoracic Surgery|April 21, 2019
Robotic-Assisted Lobectomy for Non-Small Cell Lung Cancer: A Comprehensive Institutional ExperienceDavid B Nelson, Reza J Mehran, Kyle G Mitchell, et al.
Journal of the National Cancer Institute|February 6, 2003
Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized placebo-controlled trialJonathan M Kurie, Reuben Lotan, J Jack Lee, et al.
Molecular Medicine (Cambridge, Mass.)|November 19, 2002
PI3 kinase blockade by Ad-PTEN inhibits invasion and induces apoptosis in RGP and metastatic melanoma cellsAlexis L Stewart, Abner M Mhashilkar, Xiaohong Helena Yang, et al.
Pageof 36

Showing results (241-250 of 352) with videos related to

Sort By:
Pageof 36
Plos One|June 9, 2015
Exogenous Restoration of TUSC2 Expression Induces Responsiveness to Erlotinib in Wildtype Epidermal Growth Factor Receptor (EGFR) Lung Cancer Cells through Context Specific Pathways Resulting in Enhanced Therapeutic EfficacyBingbing Dai, Shaoyu Yan, Humberto Lara-Guerra, et al.
The Annals of Thoracic Surgery|August 18, 2018
Perioperative Outcomes for Stage I Non-Small Cell Lung Cancer: Differences Between Men and WomenDavid B Nelson, Danica J Lapid, Kyle G Mitchell, et al.
The Annals of Thoracic Surgery|November 1, 2020
Liposomal Bupivacaine Intercostal Block Is Important for Reduction of Pulmonary ComplicationsErin M Corsini, Kyle G Mitchell, Nicolas Zhou, et al.
Journal of the National Cancer Institute|November 1, 2007
Proliferative changes in the bronchial epithelium of former smokers treated with retinoidsWalter N Hittelman, Diane D Liu, Jonathan M Kurie, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 18, 2018
Genetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patientsBoris Sepesi, Yuanqing Ye, Kyle G Mitchell, et al.
Clinical Pharmacology and Therapeutics|April 24, 2014
Inflammation-related genetic variations and survival in patients with advanced non-small cell lung cancer receiving first-line chemotherapyXia Pu, Michelle A Hildebrandt, Charles Lu, et al.
Scientific Reports|January 25, 2022
Combined MEK/MDM2 inhibition demonstrates antitumor efficacy in TP53 wild-type thyroid and colorectal cancers with MAPK alterationsSeyed Pairawan, Argun Akcakanat, Scott Kopetz, et al.
The Annals of Thoracic Surgery|April 21, 2019
Robotic-Assisted Lobectomy for Non-Small Cell Lung Cancer: A Comprehensive Institutional ExperienceDavid B Nelson, Reza J Mehran, Kyle G Mitchell, et al.
Journal of the National Cancer Institute|February 6, 2003
Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized placebo-controlled trialJonathan M Kurie, Reuben Lotan, J Jack Lee, et al.
Molecular Medicine (Cambridge, Mass.)|November 19, 2002
PI3 kinase blockade by Ad-PTEN inhibits invasion and induces apoptosis in RGP and metastatic melanoma cellsAlexis L Stewart, Abner M Mhashilkar, Xiaohong Helena Yang, et al.
Pageof 36